These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19435410)

  • 1. Editorial.
    Woodland DL
    Viral Immunol; 2009 Jun; 22(3):145. PubMed ID: 19435410
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral Immunology. Editorial.
    Woodland DL
    Viral Immunol; 2009 Feb; 22(1):1-2. PubMed ID: 19210220
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of malignant gliomas.
    Jaeckle KA
    Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
    [No Abstract]   [Full Text] [Related]  

  • 4. The biological significance of the immune response with special reference to parasites and cancer.
    Davies AJ; Hall JG; Targett GA; Murray M
    J Parasitol; 1980 Oct; 66(5):705-21. PubMed ID: 7463241
    [No Abstract]   [Full Text] [Related]  

  • 5. BCG immunotherapy of bladder cancer: 20 years on.
    Alexandroff AB; Jackson AM; O'Donnell MA; James K
    Lancet; 1999 May; 353(9165):1689-94. PubMed ID: 10335805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant DNA virus vectors for vaccination.
    Moss B
    Semin Immunol; 1990 Sep; 2(5):317-27. PubMed ID: 2134016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoints in viral latency.
    Redpath S; Angulo A; Gascoigne NR; Ghazal P
    Annu Rev Microbiol; 2001; 55():531-60. PubMed ID: 11544366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant formulations and their mode of action.
    Allison AC; Byars NE
    Semin Immunol; 1990 Sep; 2(5):369-74. PubMed ID: 1966859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays for monitoring cellular immune responses to active immunotherapy of cancer.
    Clay TM; Hobeika AC; Mosca PJ; Lyerly HK; Morse MA
    Clin Cancer Res; 2001 May; 7(5):1127-35. PubMed ID: 11350875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of host-cell ubiquitin pathways by viruses.
    Shackelford J; Pagano JS
    Essays Biochem; 2005; 41():139-56. PubMed ID: 16250903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of HIV-seropositive patients: preliminary report on a dose-ranging study.
    Slade H; Turner J; Abrams C; Carlo D; Salk J
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1329-31. PubMed ID: 1361349
    [No Abstract]   [Full Text] [Related]  

  • 14. [AIDS vaccine--its strategies and prospects].
    Kitamura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():530-5. PubMed ID: 8271432
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccine therapy using rgp 160 in early HIV infection.
    Redfield R; Birx D; Ketter N; Polonis V; Johnson S; Davis C; Smith G; Oster C; Burke D
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1333. PubMed ID: 1361350
    [No Abstract]   [Full Text] [Related]  

  • 16. How viruses suppress immunity.
    Lee RE
    Can Med Assoc J; 1984 Dec; 131(12):1437-42. PubMed ID: 6498697
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology during acute infections: contributions of intracellular pathogens and the CTL response.
    Ganusov VV; Antia R
    Biol Lett; 2005 Jun; 1(2):239-42. PubMed ID: 17148176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Transfer factor.
    Br Med J; 1974 May; 2(5916):397-8. PubMed ID: 4546097
    [No Abstract]   [Full Text] [Related]  

  • 19. Retroviral vectors as vaccines and immunotherapeutics.
    Jolly DJ; Warner JF
    Semin Immunol; 1990 Sep; 2(5):329-39. PubMed ID: 1966858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking the first steps towards infection.
    Teitzel G
    Trends Microbiol; 2013 Aug; 21(8):359. PubMed ID: 23910544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.